BRIEF-EMA Says CHMP Recommended Granting A Full Marketing Authorisation To Veklury

Gilead Sciences Inc:

* EMA SAYS COMMITTEE RECOMMENDED GRANTING A FULL MARKETING AUTHORISATION TO VEKLURY (REMDESIVIR), AN ANTIVIRAL MEDICINE USED TO TREAT COVID-19 Source text for Eikon: Further company coverage:

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)